Alcohol: is it detrimental to HIV infected individuals on antiretroviral therapy?

Kavita S. Joshi; Gajanan Chavan

doi:10.18203/2320-6012.ijrms20162216

Authors

Kavita S. Joshi Department of Medicine, Seth G S Medical College, Parel, Mumbai
Gajanan Chavan Department of Medicine, Seth G S Medical College, Parel, Mumbai

DOI:

https://doi.org/10.18203/2320-6012.ijrms20162216

Keywords:

Alcohol, HIV, HAART

Abstract

Background: Chronic Alcohol consumption is immunosuppressant and HIV causes immunodeficiency. Both in same patient can have detrimental effect. HIV can progress rapidly in an alcoholic patient. This study is looking for adverse effects of alcoholism on CD4 response, adherence and adverse drug reactions on patients who are on highly active antiretroviral therapy.

Methods: A prospective observational study done over period of one year after local institutional ethics committee approval was obtained. All consecutive HIV infected male patients presenting for first time and indicated to start on HAART above age of 18 years who were willing to give consent were recruited for this study. Patients with Hepatitis B and Hepatitis C were excluded from the study. Results were analyzed using ANOVA and paired T test.

Results: The CD4 counts remained lower in habitual alcoholics compared to social alcoholic and nonalcoholic study groups, P value being 0.0385 (habitual alcoholic); 0.0291 (social alcoholic) and 0.0251 (non-alcoholic) respectively. It was found (13%) alcoholic patients; 12 (8%) social alcoholic and 4 (2.7%) Non-alcoholic patients were not maintaining pill counts. 36 (24.5%) of total Patients were not maintaining pill counts. Patients consuming alcohol even did not follow up nor followed instructions, P value being 0.000.

Conclusions: Alcoholic patients were not following regularly for treatment. Hence we can conclude that alcohol has negative effect on adherence to HAART. Therefore in our part of country alcoholics should be considered as high risk groups for HIV care.

Metrics

Metrics Loading ...

References

Cahill A, Cunningham CC, Adachi M, Ishii H, Bailey SM, Fromenty B, et al. Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcoholism, Clin Experiment Res. 2002;26(6):907-15.

NACO Annual report 2014-15. Available at http://www.naco.gov.in/upload/2015%20MSLNS/Annual%20report%20_NACO_2014-15.pdf. Accessed on 15 June, 2016.

Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572-7.

Miguez MJ, Shor-Posner G, Morales G, Rodriguez A, Burbano X. HIV treatment in drug abusers: Impact of alcohol use. Addict Biol. 2003;8:33-7.

Hira SK, Dupont HL, Lanjewar DN, Dholakia YN. Severe weight loss: the predominant clinical presentation of tuberculosis in patients with HIV infection in India. National Med J India. 1998;11:256-8.

Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26:511-8.

Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Inf Dis. 2003;36:79-85-8.

Samet JH, Mulvey KP, Zaremba N, Plough A. HIV testing in substance abusers. Am J Drug Alcohol Abuse. 1999;25(2):269-80.

Prasad R, Saini JK, Gupta R, Kannaujia RK, Sarin S, Suryakant, et al. A comparative study of clinic-radiological spectrum of tuberculosis among HIV seropositive and HIV seronegative patients. Indian J Chest Dis Allied Sci. 2004;46:99-103.

Singh A, Bairy I, Shivananda PG. Spectrum of opportunistic infections in AIDS cases. Indian J Med Sci. 2003;57:16-21.

Ghate MV, Mehendale SM, Mahajan BA, Yadav R, Brahme RG, Divekar AD, et al. Relationship between clinical condition and CD4 cell counts in HIV-infected persons, Pune, Maharashtra, India. Natl Med J India. 2000;13:183-7.

Ravilglione M, Harries A, Msika R, Wilkinson D, Nunn P. Tuberculosis and HIV current status in Africa. AIDS. 1997;11(Suppl B):S115-23

Baker RC, Jerrells TR. Recent developments in alcoholism: immunological aspects. Recent Dev Alcohol. 1993;11:249-71.

Vajpayee M, Kanswal S, Seth P, Wig N. Spectrum of opportunistic infections and profiles of CD4 cell counts among AIDS patients in Northern India. Infection. 2003;31:336-40.

Kumar P, Sharma N, Sharma NC, Patnaik S. Clinical profile of tuberculosis in patients with HIV Infection/AIDS. Indian J Chest Dis Allied Sci. 2002;44:159-63.

Rupali P, Abraham OC, Zachariah A, Subramanian S, Mathai D. Aetiology of prolonged fever in antiretroviral naïve human Immunodeficiency virus-infected adults. Nat’l Med J India. 2003;16:193-9.

Khalili H, DashtiKhavidaki S, Mohraz M, Etghani A, Almasi F. Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients. Pharmcoepidemology Drug Saf. 2009;18:848-57.

Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16(2):83-8.

Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of non-adherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573-80.

Braithwaite RS, Shechter S, Chang CC, Schaefer A, Roberts MS. Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value Health. 2007;10(3):204-13.